BPC-157 exhibits potent anti-inflammatory properties, reducing the production of pro-inflammatory cytokines and modulating immune cell activity
These results cannot be generalized to TB-500 or interpreted as substantiating performance, recovery, or injury-prevention claims
Until comprehensive carcinogenicity studies are completed, individuals with active cancer, cancer history, or high genetic cancer risk should avoid BPC-157
This is particularly significant for individuals recovering from shoulder injuries or surgeries, as excessive scar tissue can impede joint movement
Diagnosis typically involves physical examination, patient history, and imaging studies like X-rays, MRI, and sometimes CT scans